| Mechanisms of antibiotic resistance JM Munita, CA Arias Virulence mechanisms of bacterial pathogens, 481-511, 2016 | 3605 | 2016 |
| The rise of the Enterococcus: beyond vancomycin resistance CA Arias, BE Murray Nature Reviews Microbiology 10 (4), 266-278, 2012 | 2045 | 2012 |
| Antibiotic-resistant bugs in the 21st century—a clinical super-challenge CA Arias, BE Murray New England Journal of Medicine 360 (5), 439-443, 2009 | 1554 | 2009 |
| Mechanisms of antibiotic resistance in enterococci WR Miller, JM Munita, CA Arias Expert review of anti-infective therapy 12 (10), 1221-1236, 2014 | 892 | 2014 |
| Enterococcal infection—treatment and antibiotic resistance CJ Kristich, LB Rice, CA Arias | 559 | 2014 |
| Management of multidrug-resistant enterococcal infections CA Arias, GA Contreras, BE Murray Clinical microbiology and infection 16 (6), 555-562, 2010 | 531 | 2010 |
| Genetic basis for in vivo daptomycin resistance in enterococci CA Arias, D Panesso, DM McGrath, X Qin, MF Mojica, C Miller, L Diaz, ... New England Journal of Medicine 365 (10), 892-900, 2011 | 441 | 2011 |
| Acquisition of a natural resistance gene renders a clinical strain of methicillin‐resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid SM Toh, L Xiong, CA Arias, MV Villegas, K Lolans, J Quinn, AS Mankin Molecular microbiology 64 (6), 1506-1514, 2007 | 435 | 2007 |
| Mechanisms of antibiotic resistance. Microbiol Spectr 4 (2) JM Munita, CA Arias | 423 | 2016 |
| Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: serologic testing (September 2020) KE Hanson, AM Caliendo, CA Arias, JA Englund, MK Hayden, MJ Lee, ... Clinical Infectious Diseases 78 (7), e150-e169, 2024 | 389* | 2024 |
| Emergence and management of drug-resistant enterococcal infections CA Arias, BE Murray Expert review of anti-infective therapy 6 (5), 637-655, 2008 | 388 | 2008 |
| Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF A Bourgogne, DA Garsin, X Qin, KV Singh, J Sillanpaa, S Yerrapragada, ... Genome biology 9, 1-16, 2008 | 336 | 2008 |
| Mechanisms of drug resistance: daptomycin resistance TT Tran, JM Munita, CA Arias Annals of the New York Academy of Sciences 1354 (1), 32-53, 2015 | 284 | 2015 |
| Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study D Van Duin, CA Arias, L Komarow, L Chen, BM Hanson, G Weston, ... The Lancet Infectious Diseases 20 (6), 731-741, 2020 | 273 | 2020 |
| A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis M Beganovic, MK Luther, LB Rice, CA Arias, MJ Rybak, KL LaPlante Clinical Infectious Diseases 67 (2), 303-309, 2018 | 248 | 2018 |
| Mechanism of action and resistance to daptomycin in Staphylococcus aureus and enterococci WR Miller, AS Bayer, CA Arias Cold Spring Harbor perspectives in medicine 6 (11), a026997, 2016 | 241 | 2016 |
| Dissemination of Methicillin-Resistant Staphylococcus aureus USA300 Sequence Type 8 Lineage in Latin America J Reyes, S Rincón, L Díaz, D Panesso, GA Contreras, J Zurita, C Carrillo, ... Clinical infectious diseases 49 (12), 1861-1877, 2009 | 237 | 2009 |
| Transferable vancomycin resistance in a community-associated MRSA lineage F Rossi, L Diaz, A Wollam, D Panesso, Y Zhou, S Rincon, A Narechania, ... New England Journal of Medicine 370 (16), 1524-1531, 2014 | 232 | 2014 |
| Transferable Plasmid-Mediated Resistance to Linezolid Due to cfr in a Human Clinical Isolate of Enterococcus faecalis L Diaz, P Kiratisin, RE Mendes, D Panesso, KV Singh, CA Arias Antimicrobial agents and chemotherapy 56 (7), 3917-3922, 2012 | 224 | 2012 |
| Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed MS Butler, V Gigante, H Sati, S Paulin, L Al-Sulaiman, JH Rex, ... Antimicrobial agents and chemotherapy 66 (3), e01991-21, 2022 | 222 | 2022 |
